Inspire Medical Systems (2DR) Ratios
Inspire Medical Systems Ratios
DE:2DR's free cash flow for Q2 2026 was $14.07M. For the 2026 fiscal year, DE:2DR's free cash flow was decreased by $-9.16M and operating cash flow was $23.23M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 6.08 | 7.13 | 7.60 | 8.66 | 6.50 |
| Quick Ratio | 4.56 | 6.22 | 7.17 | 8.47 | 6.08 |
| Cash Ratio | 1.09 | 1.70 | 2.38 | 7.22 | 5.19 |
| Solvency Ratio | 1.26 | 0.51 | -0.18 | -0.62 | -0.62 |
| Operating Cash Flow Ratio | 1.22 | 1.47 | 0.32 | 0.19 | -0.49 |
| Short-Term Operating Cash Flow Coverage | 0.00 | 0.00 | 0.00 | 0.00 | -2.19 |
| Net Current Asset Value | $ 457.50M | $ 512.12M | $ 489.44M | $ 461.16M | $ 202.50M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.04 | 0.04 | 0.04 | 0.02 | 0.12 |
| Debt-to-Equity Ratio | 0.04 | 0.05 | 0.04 | 0.02 | 0.15 |
| Debt-to-Capital Ratio | 0.04 | 0.04 | 0.04 | 0.02 | 0.13 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.06 |
| Financial Leverage Ratio | 1.16 | 1.17 | 1.18 | 1.14 | 1.29 |
| Debt Service Coverage Ratio | 1164.35 | 2730.95 | 0.00 | -24.65 | -3.42 |
| Interest Coverage Ratio | 371.93 | 1640.14 | 0.00 | -28.38 | -18.73 |
| Debt to Market Cap | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Debt Per Share | 1.10 | 1.07 | 0.85 | 0.38 | 1.33 |
| Net Debt to EBITDA | -0.91 | -1.82 | 9.42 | 10.62 | 4.67 |
| Profitability Margins | |||||
| Gross Profit Margin | 85.39% | 84.68% | 84.54% | 83.79% | 85.74% |
| EBIT Margin | 7.22% | 7.28% | -3.19% | -10.44% | -17.07% |
| EBITDA Margin | 8.75% | 8.10% | -2.73% | -9.99% | -16.55% |
| Operating Profit Margin | 5.59% | 4.49% | -6.45% | -11.67% | -17.07% |
| Pretax Profit Margin | 7.20% | 7.28% | -3.19% | -10.85% | -17.98% |
| Net Profit Margin | 15.95% | 6.67% | -3.39% | -11.00% | -18.01% |
| Continuous Operations Profit Margin | 15.95% | 6.67% | -3.39% | -11.00% | -18.01% |
| Net Income Per EBT | 221.35% | 91.54% | 106.26% | 101.38% | 100.17% |
| EBT Per EBIT | 128.93% | 162.00% | 49.43% | 93.02% | 105.32% |
| Return on Assets (ROA) | 16.03% | 6.62% | -3.13% | -7.95% | -14.25% |
| Return on Equity (ROE) | 18.62% | 7.76% | -3.69% | -9.05% | -18.36% |
| Return on Capital Employed (ROCE) | 6.28% | 5.01% | -6.73% | -9.45% | -15.70% |
| Return on Invested Capital (ROIC) | 6.26% | 4.58% | -6.73% | -9.42% | -15.14% |
| Return on Tangible Assets | 16.03% | 6.62% | -3.13% | -7.95% | -14.25% |
| Earnings Yield | 5.37% | 0.97% | -0.35% | -0.63% | -0.67% |
| Efficiency Ratios | |||||
| Receivables Turnover | 7.62 | 8.63 | 6.95 | 6.66 | 6.83 |
| Payables Turnover | 3.64 | 3.18 | 2.49 | 2.46 | 2.85 |
| Inventory Turnover | 0.92 | 1.54 | 2.85 | 5.56 | 1.93 |
| Fixed Asset Turnover | 7.51 | 8.43 | 9.97 | 16.90 | 14.23 |
| Asset Turnover | 1.01 | 0.99 | 0.92 | 0.72 | 0.79 |
| Working Capital Turnover Ratio | 1.77 | 1.52 | 1.27 | 1.17 | 0.98 |
| Cash Conversion Cycle | 345.79 | 165.27 | 33.79 | -27.80 | 114.50 |
| Days of Sales Outstanding | 47.90 | 42.31 | 52.51 | 54.79 | 53.45 |
| Days of Inventory Outstanding | 398.06 | 237.78 | 128.07 | 65.62 | 188.99 |
| Days of Payables Outstanding | 100.18 | 114.82 | 146.79 | 148.21 | 127.94 |
| Operating Cycle | 445.97 | 280.09 | 180.57 | 120.41 | 242.44 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 3.98 | 4.38 | 0.84 | 0.41 | -0.74 |
| Free Cash Flow Per Share | 2.67 | 3.06 | 0.03 | 0.09 | -0.91 |
| Dividend Paid and CapEx Coverage Ratio | 3.04 | 3.33 | 1.04 | 1.27 | -4.31 |
| Capital Expenditure Coverage Ratio | 3.04 | 3.33 | 1.04 | 1.27 | -4.31 |
| Operating Cash Flow Coverage Ratio | 3.64 | 4.10 | 0.99 | 1.30 | -0.59 |
| Operating Cash Flow to Sales Ratio | 0.13 | 0.16 | 0.04 | 0.03 | -0.09 |
| Free Cash Flow Yield | 2.90% | 1.65% | 0.02% | 0.03% | -0.40% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 18.63 | 102.99 | -281.80 | -157.54 | -149.19 |
| Price-to-Sales (P/S) Ratio | 2.97 | 6.87 | 9.54 | 17.34 | 26.87 |
| Price-to-Book (P/B) Ratio | 3.47 | 8.00 | 10.41 | 14.26 | 27.38 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 34.52 | 60.55 | 5821.23 | 2859.16 | -253.04 |
| Price-to-Operating Cash Flow Ratio | 23.16 | 42.36 | 241.79 | 611.18 | -311.75 |
| Price-to-Earnings Growth (PEG) Ratio | 0.11 | -0.29 | 5.12 | -40.44 | 5.03 |
| Enterprise Value Multiple | 33.04 | 83.03 | -339.99 | -162.96 | -157.72 |
| Enterprise Value | 2.64B | 5.40B | 5.80B | 6.64B | 6.09B |
| EV to EBITDA | 33.04 | 83.03 | -339.99 | -162.96 | -157.72 |
| EV to Sales | 2.89 | 6.73 | 9.28 | 16.28 | 26.10 |
| EV to Free Cash Flow | 33.59 | 59.25 | 5664.30 | 2684.19 | -245.76 |
| EV to Operating Cash Flow | 22.53 | 41.45 | 235.28 | 573.77 | -302.79 |
| Tangible Book Value Per Share | 26.60 | 23.17 | 19.54 | 17.67 | 8.40 |
| Shareholders’ Equity Per Share | 26.60 | 23.17 | 19.54 | 17.67 | 8.40 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | -1.21 | 0.08 | -0.06 | -0.01 | -0.00 |
| Revenue Per Share | 31.05 | 26.97 | 21.32 | 14.53 | 8.56 |
| Net Income Per Share | 4.95 | 1.80 | -0.72 | -1.60 | -1.54 |
| Tax Burden | 2.21 | 0.92 | 1.06 | 1.01 | 1.00 |
| Interest Burden | 1.00 | 1.00 | 1.00 | 1.04 | 1.05 |
| Research & Development to Revenue | 0.11 | 0.14 | 0.19 | 0.17 | 0.16 |
| SG&A to Revenue | 0.68 | 0.66 | 0.00 | 0.00 | 0.00 |
| Stock-Based Compensation to Revenue | 0.14 | 0.14 | 0.13 | 0.13 | 0.11 |
| Income Quality | 0.80 | 2.43 | -1.17 | -0.26 | 0.48 |
Currency in USD